Back to Journals » International Journal of General Medicine » Volume 4

Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common cold

Authors Yakoot M , Salem A

Published 12 January 2011 Volume 2011:4 Pages 45—51

DOI https://doi.org/10.2147/IJGM.S16266

Review by Single anonymous peer review

Peer reviewer comments 2



Mostafa Yakoot1, Amel Salem2
1Green Clinic, Alexandria, Egypt; 2Mabbarah Hospital, Alexandria, Egypt

Objective: To study the potential efficacy and tolerability of a natural multiherbal formula (Immumax) containing Echinacea extract 120 mg, garlic powder 100 mg, Nigella sativa oil 200 mg, and Panax ginseng extract 50 mg plus vitamin C 50 mg and elemental zinc 7.5 mg in the treatment of patients suffering from the common cold.
Design and setting: The study was conducted in a prospective, double-blind, randomized, controlled study design in an outpatient setting.
Patients and methods: Sixty-two eligible patients with symptoms of the common cold were randomized to either Immumax or placebo treatment groups for the duration of their symptoms or a maximum of 14 days. Resolution rates were estimated using Kaplan–Meier analysis, and resolution profiles were compared between groups using the log-rank test. The mean percentage change in total symptom severity scores at days 4 and 8 from baseline were compared between the two groups by one-way analysis of variance (ANOVA).
Results: The median (interquartile range) time to resolution of all symptoms was 8 (5–9) days in the placebo group and 4 (3–6) days in the Immumax group. The results of the log-rank test indicate that symptoms resolved significantly faster in the Immumax group than in the placebo group (P < 0.001). The mean percentage reduction in total symptom severity scores from baseline at days 4 and 8 was significantly greater in the Immumax group than in the placebo group by one-way ANOVA (P < 0.01).
Conclusion: We can conclude from our study that Immumax is helpful in reducing the duration and severity of common cold symptoms.

Keywords: Immumax, common cold, multiherbal

Creative Commons License © 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.